AzTrials
AzTrials

Aging WellNCT05511259

Assessing Causality of the Association Between Exercise and Neurocognitive Gains

A study testing exercise in people with Aging Well, run by Nanyang Technological University at 1 site in Singapore.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Brief Summary: The aim of this project is to examine: 1. The effects of a community based square stepping exercise programme on cognitive and physical functions in older adults. 2. The effects of a community based square stepping exercise programme on neuroplasticity in older adults. 3. Read more about this study

Who is it for?
Ages 55 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Aging Well
What is being tested?
exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
93 participants
Where
1 siteSingapore
Study dates
10 May 2022to 4 Apr 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Older adults aged 55-80
  • Sedentary, defined as exercise less than 3 times per week for 30 minutes

Who cannot join

  • Square stepping exercise:
  • Medical conditions preventing them from movement and/or exercise
  • Psychiatric conditions
  • Cognitive impairment of dementia
  • Upper and/or lower limb injuries in the past 6 months
  • History of falls in the past 6 months
Show all 25Show fewer
  • Current smokers
  • Neuroimaging (all the above in addition to the following)
  • Patients who have conductive, ferromagnetic, or magnet-sensitive metals implanted in head (e.g., aneurysm clip, stent).
  • Implanted medical device: e.g., cardiac implants, cochlear implant, aneurysm clips, cardiac pacemaker etc.
  • Non-removable metal braces or retainer (dental fillings ok).
  • Permanent tattoos on head.
  • Deep brain stimulators.
  • Previous brain surgery or injury.
  • Patient with epilepsy or any other seizure history, or immediate family history of epilepsy.
  • Clinical EEG that was abnormal or where seizure activity had not been ruled out.
  • Patients with history of head injury with loss of consciousness are to be investigated about the history if/before being recruited.
  • Diagnosis or possibility of neurological disorder (including stroke).
  • Psychiatric condition.
  • Major or unstable medical condition/surgery.
  • Current or suspected pregnancy or lactation.
  • Illicit drug use in the last 7 days.
  • Alcohol use in the last 12 hours or more than 3 standard drinks in last 24 hours.
  • Recent insomnia or severe sleep deprivation.
  • Participation in another study involving brain stimulation (e.g., TMS, TDCS) in the past 7 days.

Trial locations and contacts

1 site in 1 country.

Singapore1 site
  • Nanyang Technological University

    Singapore

Other trials in Singapore

About this study

Brief Summary: The aim of this project is to examine:

  1. The effects of a community based square stepping exercise programme on cognitive and physical functions in older adults.
  2. The effects of a community based square stepping exercise programme on neuroplasticity in older adults.
  3. The effects of a community based square stepping exercise programme on structural and functional brain changes in older adults.
  4. The relationship between exercise-induced changes in neuroplasticity, structural and functional brain activations, and cognitive and physical gains in older adults.
Read the detailed description

It is well known regular exercise produces both physical and cognitive benefits. Emerging evidence suggests that physical movements or exercise that have concurrent cognitive demands may have more profound effects on cognitive and brain health outcomes. One training program that incorporates these components is the square stepping exercise (SSE). First demonstrated in Japan, this community-based paradigm has already shown to reduce falls risk and presents as a convenient exercise modality for older adults, that can be conducted in a group setting or even the home. The current project aims to examine the efficacy of this SSE community programme in a Singapore context on cognitive and physical health in older adults. This study also aims to quantify the neural correlates underpinning any observed improvements in cognitive and physical function. Specifically, this project will measure indices of neuroplasticity via structural and functional magnetic resonance imaging, transcranial magnetic stimulation, and electroencephalography.

Sample size estimation: n=80 for behavioural primary outcome measures and n=40 subset of larger sample for neuroimaging and neuroplasticity secondary outcome measures [anticipated].

Conditions
Aging Well
Being tested
exercise
Keywords
healthy aging, older adults, cognition, exercise, neuroplasticity
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • exerciseOther

    Square stepping exercise

Study groups in NCT05511259
Study groupRoleWhat they receive
Exercise-CognitionExperimentalSquare Stepping Exercise
Receives: Other: exercise
No exerciseNo interventionPassive control group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Go-No-Go task change

    Error rate: Number of "Go" responses on "No-Go" trials.

    Measured: Baseline (week 0), mid-intervention (week 7 after session 12), post-intervention (week 13 after session 24)

  2. Stroop task colour words and colour blocks

    Average response time (reaction time) for the correct colour word incongruent trials.

    Measured: Baseline (week 0), mid-intervention (week 7 after session 12), post-intervention (week 13 after session 24)

  3. N-Back task change

    Number of correct responses (hits)

    Measured: Baseline (week 0), mid-intervention (week 7 after session 12), post-intervention (week 13 after session 24)

  4. Trail Making Test ((TMT) change

    B:A: Divide the time taken for TMT B by TMT A

    Measured: Baseline (week 0), mid-intervention (week 7 after session 12), post-intervention (week 13 after session 24)

  5. Digit Span task change

    Maximum accurate span length for Digit Span Forward Maximum accurate span length for Digit Span Reverse

    Measured: Baseline (week 0), mid-intervention (week 7 after session 12), post-intervention (week 13 after session 24)

  6. Modified Card Sorting task change

    Total number of perseverative errors

    Measured: Baseline (week 0), mid-intervention (week 7 after session 12), post-intervention (week 13 after session 24)

  7. Static balance (single leg) change

    Duration required to perform single leg stance on left and right legs

    Measured: Baseline (week 0), post-intervention (week 13 after session 24)

  8. Temporal gait parameters change

    11-meter gait test to examine gait speed

    Measured: Baseline (week 0), post-intervention (week 13 after session 24)

  9. Motor learning change

    Probabilistic Serial Reaction Time Task: learning index, computed using reaction time

    Measured: Baseline (week 0), post-intervention (week 13 after session 24)

Secondary outcomes (9)
  1. Change in cortical thickness

    T1 and T2 weighted images

    Measured: Baseline (week 0), post-intervention (week 13 after session 24)

  2. Change in grey matter volume

    T1 and T2 weighted images

    Measured: Baseline (week 0), post-intervention (week 13 after session 24)

  3. Change in structural topography

    T1 and T2 weighted images

    Measured: Baseline (week 0), post-intervention (week 13 after session 24)

  4. Change in white matter integrity

    Diffusion Tensor Imaging

    Measured: Baseline (week 0), post-intervention (week 13 after session 24)

  5. Change in white matter connectivity

    Diffusion Tensor Imaging

    Measured: Baseline (week 0), post-intervention (week 13 after session 24)

  6. Change in functional connectivity

    Resting state functional magnetic resonance imaging

    Measured: Baseline (week 0), post-intervention (week 13 after session 24)

  7. Brain plasticity changes

    Changes in transcranial magnetic stimulation (TMS) induced motor evoked potential amplitudes in response to theta-burst stimulation protocol

    Measured: Baseline (week 0), post-intervention (week 13 after session 24)

  8. Brain plasticity changes

    Changes in transcranial magnetic stimulation (TMS)-evoked potentials recorded from electroencephalography (EEG)

    Measured: Baseline (week 0), post-intervention (week 13 after session 24)

  9. Brain plasticity changes

    Changes in power spectral density and coherence recorded from electroencephalography (EEG)

    Measured: Baseline (week 0), post-intervention (week 13 after session 24)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Aug 2022
  2. Study start10 May 2022
  3. Primary completion4 Apr 2023
  4. Study completion4 Apr 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Intervention group: 3-month community based exercise program (square stepping exercise)
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
93 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05511259
Sponsor's protocol ID
MOE2019-T2-1-019
Status last verified
Aug 2022
First submitted
14 Mar 2022
Last updated
31 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Only de-identified data will be shared after publication and upon request. Request for data needs to justify use of data.

Questions about this trial

What is this clinical trial studying?

A study testing exercise in people with Aging Well, run by Nanyang Technological University at 1 site in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 25 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Go-No-Go task change (time frame: Baseline (week 0), mid-intervention (week 7 after session 12), post-intervention (week 13 after session 24)). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in